Case Control Study Open Access
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 14, 2016; 22(22): 5228-5236
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5228
Factors affecting occurrence of gastric varioliform lesions: A case-control study
Tian-Hui Zou, Qin-Yan Gao, Xuan Kong, Xiao-Yu Chen, Zhi-Zheng Ge, Ying-Xuan Chen, Jing-Yuan Fang, Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai 200001, China
Ru-Hua Zheng, Xiao-Ping Zou, Division of Gastroenterology and Hepatology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu Province, China
Author contributions: Zou TH performed telephone interviews of most participants and wrote the manuscript; Zheng RH performed part of the telephone interviews; Gao QY and Kong X provided analytical tools; Chen XY offered the pathological data; Ge ZZ offered the endoscopic data; Chen YX served as scientific advisors; Fang JY designed the study and edited the manuscript; all authors approved the final version of the manuscript.
Supported by National Natural Science Foundation of China, No. 31371420 (to FJY); the National Key Technology R and D Program, No. 2014BAI09B05 (to CYX); and the National Natural Science Foundation of China, No. 81402347 (to KX).
Institutional review board statement: The study was approved by Shanghai Jiao Tong University School of Medicine.
Informed consent statement: All patients gave informed consent.
Conflict-of-interest statement: No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
Data sharing statement: Statistical code and dataset available from the corresponding author at jingyuanfang@sjtu.edu.cn.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Jing-Yuan Fang, PhD, Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, No. 145 Shandong Zhonglu, Shanghai 200001, China. jingyuanfang@sjtu.edu.cn
Telephone: +86-21-63200874 Fax: +86-21-63266027
Received: January 18, 2016
Peer-review started: January 19, 2016
First decision: March 7, 2016
Revised: March 16, 2016
Accepted: March 30, 2016
Article in press: March 30, 2016
Published online: June 14, 2016
Processing time: 135 Days and 21.1 Hours

Abstract

AIM: To investigate the factors influencing the occurrence of gastric varioliform lesions (GVLs) and their possible link with gastric cancer.

METHODS: A 1:1 matched case-control study was performed to retrospectively analyze data from 1638 chronic gastritis patients who had undergone gastroscopy at one of two Chinese hospitals between 2009 and 2014. Patients with GVLs (cases) were compared to those without such lesions (controls). Endoscopic and pathological findings were recorded, along with interview information on Helicobacter pylori (H. pylori) infection, medical, drug and family histories, lifestyle and eating habits. The association between each factor and the occurrence of GVLs was estimated, and then multivariate conditional logistic regression was used to evaluate the independent factors.

RESULTS: The frequency and severity of glandular atrophy, intestinal metaplasia (IM) and low-grade intraepithelial neoplasia were significantly increased in the GVL group (P < 0.01). Overall analysis showed that H. pylori infection [3.051 (2.157, 4.317), P <0.001], allergic respiratory diseases [3.636 (2.183, 6.055), P < 0.001], work-related stress [2.019 (1.568, 2.600), P < 0.001], irregular meals [2.300 (1.462, 3.619), P < 0.001], high intake of spicy food [1.754 (1.227, 2.507), P = 0.002] and high intake of fresh fruit [0.231 (0.101, 0.529), P = 0.001] were significantly correlated with the occurrence of GVLs (positively, except for the latter). Stratified analyses indicated that pickled food consumption in patients over 50 years old [7.224 (2.360, 22.115), P = 0.001] and excessive smoking in men [2.013 (1.282, 3.163), P = 0.002] were also positively correlated, and that, for antral GVLs, vegetable consumption [0.491 (0.311, 0.776), P = 0.002] was negatively correlated.

CONCLUSION: Seven risk factors and two protective factors are determined for GVLs, which were found to be associated with premalignant abnormalities.

Key Words: Gastric cancer; Gastric varioliform lesions; Precancerous lesion; Risk factor; Varioliform gastritis

Core tip: To our knowledge, this is the first case-control study investigating the factors influencing the formation of gastric varioliform lesions, which were supposed to be associated with gastric neoplasia in previous reports. Our results indicate a potentially increased cancer risk for the affected patients, and that Helicobacter pylori infection, allergic respiratory diseases, high work-related stress, irregular meals, high intake of spicy food, pickled food consumption in elder people, excessive smoking in men, consumption of vegetables and high intake of fresh fruit are found to be correlated with the occurrence of gastric varioliform lesions.



INTRODUCTION

Varioliform gastritis (VG), or “octopus sucker” gastritis in the foreign literature and verrucous gastritis in the national literature, is a disease with a characteristic endoscopic manifestation but no specific clinical symptoms. The major endoscopic feature is the presence of gastric varioliform lesions (GVLs), namely, widespread small lesions, manifesting as round, oval or irregularly shaped elevations, often possessing a central umbilical-like depression covered in gray-colored secretion or tiny bleeds. In 1947, Moutier and Martin[1] first described two cases of this distinctive gastric mucosal disease, and then in 1978, Lambert et al[2] classified the disease, according to its site of occurrence, into “diffuse” VG when spread throughout the stomach, and “antral” VG when restricted to the antrum. These two forms of VG are thought to have different etiopathogenesis and histological manifestations[3]. VG has been recognized as a protruded type of chronic erosive gastritis in the Consensus on Chronic Gastritis in China (2012)[4], but endoscopists more often present the diagnosis as chronic gastritis with varioliform lesions.

Until recently, very little was known about the etiopathogenesis of GVLs. Malfertheiner et al[5] reported that the Helicobacter pylori (H. pylori) infection rate was 89% among 37 patients with GVLs, and their clinical symptoms and mucosal inflammation were substantially improved after effective eradication of the infection. In the national literature, most authors support this point of view and regard H. pylori as the main cause of GVLs. On the other hand, several studies have provided compelling evidence that type I hypersensitivity may play a role[6]. Andre et al[7] found a large number of IgE-containing cells in the affected gastric mucosa and a significantly increased incidence of allergic diseases in patients with GVLs, as compared with the normal population. Furthermore, they performed a randomized double-blind placebo-controlled trial to compare clinical and endoscopic outcomes in patients treated with sodium cromoglycate, cimetidine or placebo[8]. The result stated that treatment with sodium cromoglycate greatly improved both sets of outcomes, whereas treatment with cimetidine or placebo showed no appreciable effect. Other previously reported pathogenic factors include hyperacid[9] and viral infection[10].

Some reports suggest a possible association between GVLs and gastric neoplasia. In 1960, Munoz Monteavaro et al[11] observed “in situ” carcinomatous transformation in a patient with VG, and other groups have reported similar findings more recently[12,13]. The elevated lesions can persist and transform into sessile polyps and appear as a gastric carcinoma several years later; as a result, the disease was classified as a precursor to gastric cancer at the World Congress of Gastroenterology (WCOG) in 1994. Diverse risk factors are involved in gastric carcinogenesis, including bacterial, environmental, dietary and genetic variables[14]. Numerous epidemiological studies have attempted to shed light on the factors impacting gastric neoplasia and precancerous lesions; these include a history of diabetes[15], aspirin consumption[16], excessive smoking[17] and drinking[18], pickled food consumption[19], tea consumption[20], amongst others. However, the results are somewhat inconsistent due to the ethnic diversity and limited sample size. A recent systematic review concluded that smoking, drinking, red meat and pickled food were risk factors, and that fresh vegetables and fruit may be protective; there was insufficient evidence to draw conclusions regarding coffee, tea or seafood[21]. GVLs may share some of these risk factors, and clarifying the matter should provide a better understanding of this potentially premalignant condition, allowing physicians to better identify at-risk patients and to devise more effective treatment strategies. Therefore, we carried out a retrospective 1:1 matched bi-center case-control study, analyzing endoscopic and pathological data from 1638 patients with chronic gastritis. The association between potentially relevant variables and the occurrence of GVLs was systematically evaluated, with an aim to find independent risk factors and protective factors.

MATERIALS AND METHODS
Study sample and selection criteria

A 1:1 matched case-control study was conducted, analyzing data from outpatients who had undergone gastroscopy at Renji Hospital, Shanghai Jiao-Tong University School of Medicine or the Nanjing Drum Tower Hospital, Nanjing University School of Medicine between 2009 and 2014. A total of 1638 chronic gastritis patients were enrolled, all of which fell into one of two categories: those with GVLs (cases; n = 819) or those without such lesions (controls; n = 819).

To populate the case group, we searched the electronic databases of the aforementioned hospital endoscopic centers, using the following keywords: “varioliform gastritis” or “with gastric varioliform lesions” or “with erosive elevations”; then we closely examined the corresponding patient images and selected those patients having at least three typical lesions. Any disagreement was discussed by T.H. Zou and R.H. Zheng before reaching a consensus. Control patients, who were diagnosed with chronic gastritis at the same time, but without varioliform lesions, were matched one by one with the case group members, based on gender, age ± 2 years, month of examination and endoscopist. The exclusion criteria were strictly adhered to and were as follows: those who had no biopsy, those who were diagnosed with gastric cancer and those who had undergone partial or total gastrectomy. For those who had repeated examinations, we only recorded data from the first diagnostic gastroscopy.

Data extraction

The endoscopic and pathological findings were recorded. All the patients were required to undergo a gastroscopy with biopsies for the diagnosis. All parts of the upper gastrointestinal tract were carefully examined for any lesions by experienced endoscopists, and at least two biopsies were taken from the antrum. If suspected lesions were found, 2 to 5 more biopsies were taken. Pathological examinations for chronic gastritis were made by experienced pathologists according to the visual analogue scale (VAS) in the updated Sydney System[22,23] that is associated with the Consensus on Chronic Gastritis in China. Histological diagnosis of intraepithelial neoplasia was made based on the World Health Organization (WHO) classification[24]. To concretely differentiate the severity of inflammation, glandular atrophy or IM in the present study, a scheme was introduced using the following calculation: grading index = (S1×B1 + S2×B2 +…+ Sn×Bn)/Bn, where S is the severity of a particular biopsy specimen, B is the number of the relevant specimen and n is the quantity of specimens[25].

H. pylori infection was detected using a H. pylori rapid urease test during endoscopic examination, HE and Giemsa staining of biopsy specimens, and a 13C urea breath test. We defined a positive result as meeting one of the following two criteria: (1) the rapid urease test or HE staining was positive; or (2) if both urease and HE results were negative, yet the specimen was highly inflamed, Giemsa staining was added or a 13C urea breath test was performed, and a positive outcome was considered indication of H. pylori infection. A 13C urea breath test was subsequently used when evaluating the effect of eradication on H. pylori infection.

A questionnaire was designed by the authors and it was used to conduct telephone interviews with all patients in the study. The investigators were trained to be polite and methodical during interviews and they avoided calling patients at working, or otherwise busy hours. The questionnaire requested information on the patient’s gender, age, H. pylori infection history, medical history, allergic diseases, drug history, family history, long-term lifestyle and eating habits. H. pylori infection history was categorized according to four different conditions: currently infected, but with no previous history of infection; chronic (repeated or persistent) infection; past infection that has been completely eradicated; no current or past infection. Allergic diseases consisted of bronchial asthma, allergic rhinitis, allergic skin disease, drug allergy, etc. The presence of allergic diseases was mainly based on the interview data, and the authors made the judgment with reference to the guideline of diagnosis for each disease. Lifestyle variables included sleep quality, work-related stress, tobacco smoking and alcohol consumption. Eating habits comprised irregular meals, intake of spicy food, pickled food, fried food, fresh fruit and vegetables; consumption of a particular food type over four time per week was considered high.

Statistical analysis

Statistical analyses were performed using SPSS Version 20.0 (SPSS Inc., Chicago, IL, United States). Measurement data were compared between the two groups using a paired t-test; where appropriate, numerical data were subjected to a chi-square test, while categorical data using a Mann-Whitney test. Single-factor analysis was used to estimate the association between each potential factor and GVLs, and then multivariate conditional Logistic regression analysis was applied to determine the independent risk and protective factors. Odds ratios (ORs) with 95% confidence intervals (95%CIs) were used to assess the magnitude of the associations. A two-sided P-value < 0.05 was considered statistically significant.

RESULTS

The systematic database search yielded 268538 man-hours of gastroscopy over the five-year period of interest. Following the inclusion/exclusion criteria and the 1:1 matched design, 1638 subjects were selected to populate the case and control groups. A flow chart of the selection process is presented in Figure 1. There were 448 men and 371 women in the case group, with a mean age of 53.40 ± 11.41 years (ranging from 18 to 87 years old). The basic, endoscopic and pathological characteristics of the case group are shown in Table 1.

Table 1 Characteristics of the case group n (%).
Characteristic
In total819 (100)
Hospital
Renji491 (60.0)
Drum tower328 (40.0)
Age (yr)
< 50278 (33.9)
≥ 50, < 60289 (35.3)
≥ 60252 (30.8)
Gender
Men448 (54.7)
Women371 (45.3)
Illness part
Antral form806 (98.4)
Diffuse form13 (1.6)
H. pylori infection
H. pylori (+)263 (32.1)
H. pylori (-)556 (67.9)
Histology
Glandular atrophy363 (44.3)
IM265 (32.4)
Intraepithelial neoplasia92 (11.2)
Figure 1
Figure 1 Flow chart of participant selection in the case-control study.
Analysis of histological data

We compared the frequencies of H. pylori infection, glandular atrophy, IM and intraepithelial neoplasia between the cases and controls using a χ2 test. The difference was significant for H. pylori infection (OR = 2.275, 95%CI: 1.801-2.872, P < 0.01), especially in the patients with diffuse GVLs. We also noted statistically significant findings in the pooled analysis for the association between glandular atrophy, with or without IM, and the formation of such lesions. Furthermore, a significantly increased risk of low-grade intraepithelial neoplasia was observed in the case group (OR = 1.468, 95%CI: 1.052-2.049, P = 0.023); this is known to be a premalignant condition. When the patients were further stratified according to VG form, the differences between patients with antral lesions and their matched controls were significant for glandular atrophy and IM, but not for intraepithelial neoplasia. On the other hand, diffuse lesions were strongly associated with all these histological parameters, including intraepithelial neoplasia. The results of the overall and stratified analyses are presented in Table 2.

Table 2 Overall and stratified analyses of histological data in the case-control study.
CaseControlOR [95%CI]P-value
Overall analysis
H. pylori (+)2631412.275 [1.801, 2.872]< 0.001b
Glandular atrophy3632711.610 [1.317, 1.967]< 0.001b
IM2651821.674 [1.343, 2.087]< 0.001b
Intraepithelial neoplasia92651.468 [1.052, 2.049]0.023a
Antral form
H. pylori (+)2541392.208 [1.745, 2.794]< 0.001b
Glandular atrophy3412681.472 [1.202, 1.803]< 0.001b
IM4091793.609 [2.908, 4.479]< 0.001b
Intraepithelial neoplasia79651.239 [0.878, 1.747]0.222
Diffuse form
H. pylori (+)9212.375 [1.828, 83.767]0.015a
Glandular atrophy133< 0.001
IM1130.005
Intraepithelial neoplasia12018.333 [2.522, 133.26]< 0.001b

Indices for grading inflammation, glandular atrophy and IM were calculated separately for the GVL patients and their matched controls. Paired t-tests showed that all these indices were significantly increased in the case group (P < 0.01).

Analysis of telephone interview data

For 49 patients, the contact number was incomplete or incorrect, and 94 declined to answer the questionnaire. Thus, there was a total of 1352 participants, comprising 676 people from each group; the answering ratio was 82.5%. Single-factor analyses of potential factors demonstrated that current infection with H. pylori (OR = 2.203), chronic infection with H. pylori (OR = 2.493), bronchial asthma (OR = 6.837), allergic rhinitis (OR = 2.963), family history of gastric cancer (OR = 1.926), high work-related stress (OR = 1.871), irregular meals (OR = 1.703), and high intake of spicy food (OR = 1.540) were positively associated with the occurrence of GVLs, while high intake of fresh fruit was negatively associated (OR = 0.721).

We found a negative correlation between current and chronic infection with H. pylori (Pearson coefficient, -0.113), and a positive correlation between bronchial asthma and allergic rhinitis (Pearson coefficient, 0.151). No correlation was found for any other factors. For subsequent analyses, we combined current and chronic infection into a single “H. pylori infection” category, and asthma and rhinitis were combined into “allergic respiratory diseases”. Based on the results of single-factor analyses, we included the factors with a P-value less than 0.05 into the multivariate conditional Logistic regression equation. The adjusted analysis suggested that H. pylori infection, allergic respiratory diseases, high work-related stress, irregular meals and high intake of spicy food were independent risk factors for the formation of GVLs; and that high intake of fresh fruit was an independent protective factor. Table 3 shows the overall results of the single-factor and multivariate analyses.

Table 3 Overall single-factor and multivariate analyses of impact factors in the case-control study.
Impact factorUnivariate analysis
Multivariate analysis
OR95%CIP-valueOR95%CIP-value
H. pylori infection2.329[1.802, 3.011]< 0.001b3.051[2.157, 4.317]< 0.001b
Allergic Res. Dis.3.745[2.365, 5.930]< 0.001b3.636[2.183, 6.055]< 0.001b
Family history of GC1.926[1.059, 3.503]0.029a1.628[0.801, 3.309]0.178
Stress ↑1.871[1.344, 2.603]< 0.001b2.019[1.568, 2.600]< 0.001b
Irregular meals1.703[1.184, 2.449]0.004b2.300[1.462, 3.619]< 0.001b
Spicy food ↑1.540[1.156, 2.052]0.003b1.754[1.227, 2.507]0.002b
Fresh fruit ↑0.721[0.533, 0.974]0.033a0.231[0.101, 0.529]0.001b
Stratified analysis of telephone interview data

The participants were stratified by age, gender and VG form, and the results of the subsequent analysis are shown in Table 4. For those under 50 years old, high intake of fried food was significantly more common in the GVL group (P = 0.038) under univariate analysis; however, the correlation was not significant in the final multivariate analysis, suggesting that fried food intake may be a confounding factor. In those ≥ 50 years old, univariate and multivariate analyses indicated that pickled food consumption was a new independent risk factor for GVLs. In males, excessive smoking was also found to be a new independent risk factor, while in females, allergic skin diseases seemed to be a confounding factor. For antral form, single-factor analyses showed significant differences between cases and controls for fried food consumption and intake of vegetable side dishes, but only the latter factor was confirmed as an independent factor by the adjusted multivariate analysis. For diffuse form, current or chronic H. pylori infection was found in more than half of the affected patients, whereas only two matched controls had ever been infected. The diffuse form seemed to be more highly correlated with H. pylori infection, but with only thirteen pairs of participants making up the sample, no more than a general tendency could be assessed. Allergic respiratory diseases and a family history of gastric cancer were more frequent in patients with diffuse varioliform lesions vs matched controls.

Table 4 Stratified single-factor and multivariate analyses of impact factors in the case-control study.
FactorCaseControlUnivariate analysis
Multivariate analysis
OR [95%CI]P-valueOR [95%CI]P-value
Age < 50 yr
H. pylori infection69372.224 [1.419, 3.487]< 0.001b1.968 [1.222, 3.170]0.005b
Allergic Res. Dis.34113.445 [1.700, 6.978]< 0.001b3.784 [1.715, 8.347]0.001b
Stress ↑41241.858 [1.083, 3.189]0.023a1.452 [1.076, 1.960]0.015a
Irregular meals40251.723 [1.008, 2.946]0.045a2.207 [1.112, 4.381]0.024a
Fried food ↑56381.622 [1.025, 2.567]0.038a1.459 [0.846, 2.517]0.174
Spicy food ↑50331.654 [1.021, 2.681]0.040a1.838 [1.011, 3.342]0.046a
Age ≥ 50 yr
H. pylori infection151792.386 [1.745, 3.263]< 0.001b3.402 [2.149, 5.386]< 0.001b
Allergic Res. Dis.51143.988 [2.173, 7.319]< 0.001b4.894 [2.164, 11.069]< 0.001b
Stress ↑68391.879 [1.237, 2.855]0.003b2.265 [1.594, 3.219]< 0.001b
Irregular meals44271.699 [1.032, 2.798]0.035a1.680 [0.918, 3.074]0.092
Picked-food cons.1491221.334 [1.001, 1.778]0.049a7.224 [2.360, 22.115]0.001b
Spicy food ↑86621.481 [1.036, 2.117]0.031a1.786 [1.114, 2.863]0.016a
Fresh fruit ↑3874050.637 [0.409, 0.993]0.045a0.422 [0.178, 1.001]0.050
Male
H. pylori infection116672.054 [1.458, 2.893]< 0.001b3.445 [2.114, 5.612]< 0.001b
Allergic Res. Dis.42104.599 [2.272, 9.310]< 0.001b6.563 [2.832, 15.209]< 0.001b
Smoking99761.410 [1.003, 1.981]0.047a2.013 [1.282, 3.163]0.002b
Stress ↑63342.023 [1.298, 3.154]0.002b2.096 [1.489, 2.950]< 0.001b
Irregular meals52341.614 [1.021, 2.551]0.039a2.201 [1.262, 3.839]0.005b
Spicy food ↑79571.488 [1.022, 2.165]0.037a2.167 [1.285, 3.653]0.004b
Female
H. pylori infection104492.727 [1.850, 4.021]< 0.001b3.031 [1.897, 4.844]< 0.001b
Allergic Res. Dis.43153.183 [1.726, 5.867]< 0.001b3.502 [1.691, 7.255]0.001b
Allergic skin Dis.1553.106 [1.114, 8.660]0.023a3.223 [0.966, 10.748]0.057
Stress ↑46291.694 [1.032, 2.780]0.036a1.873 [1.356, 2.589]< 0.001b
Irregular meals32181.872 [1.026, 3.415]0.039a2.027 [0.905, 4.538]0.086
Spicy food ↑57381.619 [1.036, 2.530]0.033a2.185 [1.236, 3.861]0.007b
Antral form
H. pylori infection2111142.248 [1.734, 2.914]< 0.001b3.124 [2.192, 4.452]< 0.001b
Allergic Res. Dis.80253.552 [2.237, 5.639]< 0.001b3.432 [2.062, 5.712]< 0.001b
Stress ↑107631.833 [1.315, 2.554]< 0.001b1.984 [1.544, 2.550]< 0.001b
Irregular meals83521.681 [1.168, 2.422]0.005b2.191 [1.407, 3.412]0.001b
Fried food cons.2021691.281 [1.007, 1.629]0.044a1.338 [0.955, 1.876]0.091
Spicy food ↑133951.500 [1.124, 2.002]0.006b1.705 [1.188, 2.447]0.004b
Vegetable Cons.2272620.797 [0.637, 0.996]0.046a0.491 [0.311, 0.776]0.002b
DISCUSSION

As is widely accepted, intestinal-type gastric carcinogenesis is a multi-stage process, developing from chronic gastritis through a series of precancerous abnormalities to gastric carcinoma[26,27]. In addition, H. pylori infection is thought to be the key promoter[28,29]. These precursor conditions include chronic atrophic gastritis with or without IM, with a reported malignancy rate of 0.5%-1%[30,31], and intraepithelial neoplasia[32], which is classified from low to high grade according to WHO specifications. It is reported that 0%-15% of low-grade intraepithelial neoplasia could progress to high-grade, which has an extremely high malignancy rate of 25%-85%[33]. In the present study, the frequency and severity of glandular atrophy, IM and low-grade intraepithelial neoplasia were significantly elevated in the case group, indicating that the presence of GVLs is a potential risk factor for cancer. Nevertheless, no high-grade intraepithelial neoplasia was observed, and the results were inconsistent when analysis was restricted to antral varioliform lesions. Thus, this malignancy risk should be further investigated via a large-scale prospective study.

In view of the association between GVLs and H. pylori infection status, the literature is somewhat inconclusive[34]. Our analysis showed a statistically significant difference in infection rates between GVL patients (32.1%) and controls (17.2%). The adjusted analysis of the interview data indicated that H. pylori infection, especially chronic persistent infection, was a pathogenic factor. In contrast, no correlation existed where infections had been successfully treated. Thus, H. pylori eradication and regular endoscopic follow-ups should be key components of the treatment for GVLs.

European researchers have suggested that there may be an allergic component in the pathogenesis of the disease, specifically that excessive histamine release could play a central role[7,35]; however, no evidence for this has been reported for Chinese patients. Interestingly, we found that the frequency of allergic diseases was increased in patients with varioliform lesions, in particular bronchial asthma and allergic rhinitis. There were 112 GVL patients (16.6%) with at least one allergic disease, and the multivariate analysis confirmed that allergic respiratory disease was an independent risk factor. Family history of gastric carcinoma has been reported as a risk factor for gastric carcinogenesis[36,37], but it was not associated with GVLs in our study. Diffuse form appeared to have a more positive association with allergic diseases and family history of gastric cancer, yet the results were not conclusive owing to the limited sample size, and will thus need to be verified by larger studies in the future.

In the pooled multivariate analysis, the independent risk factors were high work-related stress, irregular meals, and high intake of spicy food, and the one potentially protective factor was high intake of fresh fruit. The stratified analyses indicated that pickled food consumption in people over 50 years old and excessive smoking in men were also risk factors. Intake of vegetable side dishes was found to be negatively correlated with the antral form of GVLs. Indeed, certain habits of daily life could serve as important risk factors for gastric cancer. Previous studies revealed a close association between negative psychological factors like nervousness or anxiety and susceptibility to neoplasia[38,39]. Our participants with high work-related stress could have an increased risk of gastric malignancy, which may be related to constant anxiety-induced stimulation of the sympathetic system. Smoking is also considered a pathogenic factor for multiple cancers. A 50-year observational study of 34439 British doctors indicated that cigarette smoking was a risk factor in the progression of 14 different cancers including gastric carcinoma[40]. In the present study, excessive smoking in men contributed significantly to the risk of GVLs, but not in women, indicating possible male predominance in the morbidity of the disease. Concerning food consumption, pickled foods have been associated with the development of esophageal and gastric cancers, which can damage gastric mucosa and exacerbate the inflammation caused by H. pylori[41]. In recent times, Chinese dietary habits have changed dramatically. Pickled food may now be less popular in younger sections of the population, whereas spicy foods have greatly increased in popularity. Although capsaicin in spicy food has been shown to help counter the growth of H. pylori[42], we found that high intake of spicy food was a risk factor for varioliform lesions. The reason could be related to oncogene exposure or a chemical process during production. Meanwhile, the present study also provided factors that potentially offer some protection against GVLs. Intake of fresh vegetables and fruit has been reported to beneficial for avoidance of gastric neoplasia[43], which is consistent with the corresponding reduction in the frequency of GVLs seen in our study.

Several limitations of the present study must be taken into account. First, it is a retrospective analysis, for which recall bias and selection bias cannot be completely removed; a prospective study would be required to establish a convincing causal relationship between the factors and the disease. Second, the conclusions of the stratified analyses may be of limited value because of the small sample size, especially in the diffuse form group. Thus, some of the results in our study should be interpreted cautiously. Third, other relevant variables such as body mass index (BMI), hyperlipidemia, ABO blood group, consumption of coffee, carbonated drinks and bean products were not included; in addition, several factors such as the type of cigarette or alcohol consumed, medication dose and professional mental scale were not precisely classified. If the above factors were included in the multivariate regression equation, our results could have been very different. Future studies should therefore use a more complete set of variables.

To the best of our knowledge, this is the first case-control study investigating the factors influencing the formation of GVLs. The results suggest a potentially increased cancer risk for the affected patients, and that H. pylori infection, allergic respiratory diseases, high work-related stress, irregular meals, high intake of spicy food, pickled food consumption in older people, and excessive smoking in men were all positively correlated with the occurrence of GVLs. In contrast, consumption of vegetables and high intake of fresh fruit were found to be negatively correlated and therefore potentially protective. In summary, our results suggest that formation of GVLs can be reduced by maintaining a healthy lifestyle and positive attitude, while ensuring that allergic diseases and H. pylori infection are treated effectively. We suggest that a prospective study should be carried out in the future to examine the morphological and pathological evolution of GVLs, and thereby clarify their relationship with gastric malignancy. A large-scale, well-designed clinical trial is also warranted to provide more precise and robust conclusions on this matter.

COMMENTS
Background

Researchers discovered the presence of gastric varioliform lesions (GVLs) over 60 years ago, but until now, very little was known about the etiopathogenesis and progression. So the authors try to provide a better understanding of this potentially premalignant disease in the present case-control study.

Research frontiers

Previous reports suggested a possible association between GVLs and gastric cancer. And the disease was classified as a precursor to gastric cancer at the World Congress of Gastroenterology in 1994. More recently, Zhang et al performed a proteomic analysis to provide more molecular biological details of GVLs. The important differential proteins could serve as potential biomarkers for the early diagnosis of gastric cancer.

Innovations and breakthroughs

This is the first case-control study investigating the factors influencing the formation of GVLs, and the manuscript provide a better understanding of this potentially premalignant condition, allowing physicians to better identify at-risk patients and to devise more effective treatment strategies.

Applications

A large-scale, well-designed prospective study should be carried out in the future to examine the morphological and pathological evolution of GVLs, and thereby clarify their relationship with gastric malignancy.

Terminology

The term GVLs in the present study is a synonym of varioliform gastritis. The major endoscopic feature of such lesions is widespread small lesions, possessing a central umbilical-like depression covered in gray-colored secretion or tiny bleeds. Patients in China are affected more often by the antral type of the disease, thus endoscopists present the diagnosis as GVLs.

Peer-review

Patients diagnosed in an early stage of gastric cancer present an excellent prognosis, with a five-year survival rate greater than 90%. This well conducted and written retrospective case-control study considers the different risk and protective factors influencing the occurrence of GVLs and their possible link with development of gastric cancer.

Footnotes

P- Reviewer: Tanimoto MA, Vorobjova T S- Editor: Ma YJ L- Editor: Wang TQ E- Editor: Zhang DN

References
1.  Moutier F, Martin J. [Deux cas de gastrite varioliforme]. Arch Mal Appar Dig Mal Nutr. 1947;36:155-160.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Lambert R, André C, Moulinier B, Bugnon B. Diffuse varioliform gastritis. Digestion. 1978;17:159-167.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Haot J, Jouret A, Willette M, Gossuin A, Mainguet P. Lymphocytic gastritis--prospective study of its relationship with varioliform gastritis. Gut. 1990;31:282-285.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Fang JY, Liu WZ, Shi Y, Ge ZZ, Xiao SD. Consensus on chronic gastritis in China--Second National Consensus Meeting on Chronic Gastritis (14-16 September 2006 Shanghai, China). J Dig Dis. 2007;8:107-119.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 27]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
5.  Malfertheiner P, Stanescu A, Baczako K, Bode G, Ditschuneit H. Chronic erosive gastritis--a therapeutic approach with bismuth. Scand J Gastroenterol Suppl. 1988;142:87-92.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Monaci M, Borrelli D. [On the subject of varioliform gastritis with special reference to its allergic character and its relation to gastric ulcer]. Arch De Vecchi Anat Patol. 1960;33:647-670.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Andre C, Moulinier B, Andre F, Daniere S. Evidence for anaphylactic reactions in peptic ulcer and varioliform gastritis. Ann Allergy. 1983;51:325-328.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  André C, Gillon J, Moulinier B, Martin A, Fargier MC. Randomised placebo-controlled double-blind trial of two dosages of sodium cromoglycate in treatment of varioliform gastritis: comparison with cimetidine. Gut. 1982;23:348-352.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Murata I, Yoshikawa I, Kuroda T, Tabaru A, Miura T, Otsuki M. Varioliform gastritis and duodenitis associated with protein-losing gastroenteropathy, treated with omeprazole. J Gastroenterol. 1996;31:109-113.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Zhang L, Hou YH, Wu K, Zhai JS, Lin N. Proteomic analysis reveals molecular biological details in varioliform gastritis without Helicobacter pylori infection. World J Gastroenterol. 2010;16:3664-3673.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
11.  Munoz Monteavaro C, Mendoza D, Palma E. [Varioliform gastritis with “in situ” carcinomatous transformation]. An Fac Med Univ Repub Montev Urug. 1960;45:72-77.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Cappell MS, Green PH, Marboe C. Neoplasia in chronic erosive (varioliform) gastritis. Dig Dis Sci. 1988;33:1035-1039.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Gallina F, Benedetti-Valentini F. [Varioliform gastritis associated with gastric ulcer simulating a neoplasm]. Riv Gastroenterol. 1963;15:85-94.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Zou TH, Wang ZH, Fang JY. Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis. Tumour Biol. 2013;34:2441-2450.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 12]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
15.  Xu CX, Zhu HH, Zhu YM. Diabetes and cancer: Associations, mechanisms, and implications for medical practice. World J Diabetes. 2014;5:372-380.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 89]  [Cited by in F6Publishing: 92]  [Article Influence: 9.2]  [Reference Citation Analysis (1)]
16.  Tian W, Zhao Y, Liu S, Li X. Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev. 2010;19:288-298.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 58]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
17.  La Torre G, Chiaradia G, Gianfagna F, De Lauretis A, Boccia S, Mannocci A, Ricciardi W. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori. 2009;95:13-22.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Jarl J, Heckley G, Brummer J, Gerdtham UG. Time characteristics of the effect of alcohol cessation on the risk of stomach cancer--a meta-analysis. BMC Public Health. 2013;13:600.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 11]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
19.  D’Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012;31:489-498.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 216]  [Cited by in F6Publishing: 223]  [Article Influence: 18.6]  [Reference Citation Analysis (0)]
20.  Yu F, Jin Z, Jiang H, Xiang C, Tang J, Li T, He J. Tea consumption and the risk of five major cancers: a dose-response meta-analysis of prospective studies. BMC Cancer. 2014;14:197.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 28]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
21.  Lee YY, Derakhshan MH. Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med. 2013;16:358-365.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161-1181.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Sipponen P, Price AB. The Sydney System for classification of gastritis 20 years ago. J Gastroenterol Hepatol. 2011;26 Suppl 1:31-34.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 47]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
24.  Endo S, Dousei T, Yoshikawa Y, Hatanaka N, Taniyama K, Yamauchi A, Kamiike W, Nishijima J. Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification. Int Surg. 2012;97:335-339.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 15]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
25.  Chooi EY, Chen HM, Miao Q, Weng YR, Chen XY, Ge ZZ, Xiao SD, Fang JY. Chronic atrophic gastritis is a progressive disease: analysis of medical reports from Shanghai (1985-2009). Singapore Med J. 2012;53:318-324.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554-3560.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975;2:58-60.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Wong BC, Zhang L, Ma JL, Pan KF, Li JY, Shen L, Liu WD, Feng GS, Zhang XD, Li J. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut. 2012;61:812-818.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 110]  [Cited by in F6Publishing: 107]  [Article Influence: 8.9]  [Reference Citation Analysis (0)]
29.  Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-789.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3126]  [Cited by in F6Publishing: 3061]  [Article Influence: 133.1]  [Reference Citation Analysis (0)]
30.  de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, Kuipers EJ. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945-952.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 483]  [Cited by in F6Publishing: 533]  [Article Influence: 33.3]  [Reference Citation Analysis (0)]
31.  den Hoed CM, Holster IL, Capelle LG, de Vries AC, den Hartog B, Ter Borg F, Biermann K, Kuipers EJ. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. Endoscopy. 2013;45:249-256.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 67]  [Cited by in F6Publishing: 69]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
32.  Won CS, Cho MY, Kim HS, Kim HJ, Suk KT, Kim MY, Kim JW, Baik SK, Kwon SO. Upgrade of Lesions Initially Diagnosed as Low-Grade Gastric Dysplasia upon Forceps Biopsy Following Endoscopic Resection. Gut Liver. 2011;5:187-193.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 21]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
33.  Park SY, Jeon SW, Jung MK, Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH. Long-term follow-up study of gastric intraepithelial neoplasias: progression from low-grade dysplasia to invasive carcinoma. Eur J Gastroenterol Hepatol. 2008;20:966-970.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 61]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
34.  Kato T, Yagi N, Kamada T, Shimbo T, Watanabe H, Ida K. Diagnosis of Helicobacter pylori infection in gastric mucosa by endoscopic features: a multicenter prospective study. Dig Endosc. 2013;25:508-518.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in F6Publishing: 96]  [Article Influence: 8.7]  [Reference Citation Analysis (0)]
35.  Caporali R, Luciano S. Diffuse varioliform gastritis. Arch Dis Child. 1986;61:405-407.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol. 2003;56:1-9.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Peddanna N, Holt S, Verma RS. Genetics of gastric cancer. Anticancer Res. 1995;15:2055-2064.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Huiping C, Kristjansdottir S, Bergthorsson JT, Jonasson JG, Magnusson J, Egilsson V, Ingvarsson S. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Eur J Cancer. 2002;38:728-735.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  González CA, Pera G, Agudo A, Palli D, Krogh V, Vineis P, Tumino R, Panico S, Berglund G, Simán H. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer. 2003;107:629-634.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 158]  [Cited by in F6Publishing: 159]  [Article Influence: 7.6]  [Reference Citation Analysis (0)]
40.  Doll R, Peto R, Boreham J, Sutherland I. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer. 2005;92:426-429.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 192]  [Cited by in F6Publishing: 205]  [Article Influence: 10.8]  [Reference Citation Analysis (0)]
41.  Wang XQ, Terry PD, Yan H. Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol. 2009;15:2204-2213.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 114]  [Cited by in F6Publishing: 117]  [Article Influence: 7.8]  [Reference Citation Analysis (0)]
42.  Jones NL, Shabib S, Sherman PM. Capsaicin as an inhibitor of the growth of the gastric pathogen Helicobacter pylori. FEMS Microbiol Lett. 1997;146:223-227.  [PubMed]  [DOI]  [Cited in This Article: ]
43.  Jenab M, Riboli E, Ferrari P, Sabate J, Slimani N, Norat T, Friesen M, Tjønneland A, Olsen A, Overvad K. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis. 2006;27:2250-2257.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 94]  [Cited by in F6Publishing: 87]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]